Arm Announces Earnings Release Date for Second Quarter Fiscal Year Ended 2026

Arm Holdings plc (NASDAQ: ARM) will report financial results for the second quarter of fiscal year 2026 on Wednesday, Nov. 5, 2025, after market close. The company will host a conference call via audio webcast at 14:00 Pacific Time (17:00 Eastern Time / 22:00 Greenwich Mean Time) to review its financial results and business outlook.

The live audio webcast will be available at: https://edge.media-server.com/mmc/p/ujw5pboy and a replay of the conference call can be accessed on http://investors.arm.com / shortly afterwards. The replay will be available for four weeks.

About Arm

Arm is the industry's highest-performing and most power-efficient compute platform with unmatched scale that touches 100 percent of the connected global population. To meet the insatiable demand for compute, Arm is delivering advanced solutions that allow the world's leading technology companies to unleash the unprecedented experiences and capabilities of AI. Together with the world's largest computing ecosystem and 22 million software developers, we are building the future of AI on Arm.

All information is provided "as is" and without warranty or representation. This document may be shared freely, attributed and unmodified. Arm is a registered trademark of Arm Limited (or its subsidiaries or affiliates). All brands or product names are the property of their respective holders. © 1995-2025 Arm Limited.

Media
Kristen Ray
Kristen.Ray@arm.com

Investors
Arm Investor Relations
Investor.Relations@arm.com

News Provided by Business Wire via QuoteMedia

ARM
The Conversation (0)
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), a drug discovery company developing novel therapeutics for autism spectrum disorder ("ASD") and related neurodevelopmental disorders, is... Keep Reading...
Miivo Completes Acquisition of First Five Partners

Miivo Completes Acquisition of First Five Partners

Miivo AI Inc. (TSXV: MIVO) (OTCQB: MIVOF) (FSE: L7S0) ("Miivo" or the "Company") is pleased to announce that it has completed its previously announced acquisition of 100% of the issued and outstanding shares of First Five Partners Sàrl ("First Five"), a Switzerland-based sports advisory,... Keep Reading...
Elton Resources

Elton Resources Now Trading on TSXV!

Elton Resources Corp. (TSXV: DBAY) (formerly, Chicane Capital I Corp.) (the "Company") is pleased to announce that the common shares of the Company (CUSIP 29035T302 / ISIN CA29035T3029) have commenced trading on the TSX Venture Exchange ("TSXV") under the symbol "DBAY" at market open on October... Keep Reading...
Apex Grants Option to Acquire a Mineral Claim

Apex Grants Option to Acquire a Mineral Claim

Apex Resources Inc. (TSXV: APX,OTC:SLMLF) (OTCID: SLMLF) ("Apex" or the "Company") announces that it has entered into an option agreement effective October 1, 2026 (the "Option Agreement") with ReOsiris Inc. ("ReOsiris"), an arm's-length party, pursuant to which ReOsiris has been granted the... Keep Reading...
MIIVO to Acquire First Five Partners, an AI Specialist in the Sports Sector

MIIVO to Acquire First Five Partners, an AI Specialist in the Sports Sector

Miivo AI Inc. (TSXV: MIVO,OTC:MIVOF) (OTCQB: MIVOF) (FSE: L7S0) ("Miivo" or the "Company") is pleased to announce that it has entered into a share purchase agreement dated September 29, 2026 (the "Agreement") to acquire 100% of the issued and outstanding shares of First Five Partners Sàrl... Keep Reading...

Interactive Chart

Latest Press Releases

Related News